Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of plasma phytosterol levels in predicting lipid-lowering effect of ezetimibe in HIV-infected subjects on protease inhibitors
2006-006156-36Phase 2Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ezetimibe in human immunodeficiency virus infection (HIV) and hypercholesterolemia, sponsored by Hospital Clínic de Barcelona. Primary endpoint: Primary: Change in lipid profile after 8 weeks. Started Apr 2007; status: active.
02
Drugs
ezetimibe
03
Conditions
human immunodeficiency virus infection (HIV)hypercholesterolemia
Beyond the preview
Go deeper on 2006-006156-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006156-36.